“…It is, therefore, better to compare the efficacy of our screening strategy to screening strategies evaluated in other medical domains, including cardiovascular disease and cancer screening. 42 , 43 , 44 In this way, the QALY gain by our screening is relatively large. For instance, the QALY gain with cardiovascular risk screening among patients with rheumatoid arthritis is 0.09 per screened individual.…”